Aptamer Group plc (LON:APTA – Get Free Report) fell 8.8% during trading on Tuesday . The company traded as low as GBX 0.80 ($0.01) and last traded at GBX 0.84 ($0.01). 9,760,345 shares were traded during mid-day trading, a decline of 46% from the average session volume of 18,001,191 shares. The stock had previously closed at GBX 0.93 ($0.01).
Aptamer Group Stock Down 8.3%
The stock has a fifty day moving average of GBX 0.72 and a 200-day moving average of GBX 0.46. The stock has a market cap of £22.87 million, a PE ratio of -302.86 and a beta of -0.52.
Insiders Place Their Bets
In related news, insider Adam Hargreaves bought 5,000,000 shares of the firm’s stock in a transaction on Monday, September 8th. The shares were bought at an average cost of GBX 1 per share, for a total transaction of £50,000. 8.57% of the stock is owned by corporate insiders.
About Aptamer Group
Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.
Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.
See Also
- Five stocks we like better than Aptamer Group
- ESG Stocks, What Investors Should Know
- How The Weak Dollar Is Fueling These Global Stock Surges
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Recession-Ready Stocks That Thrive When the Economy Sputters
- 5 Top Rated Dividend Stocks to Consider
- 3 Automation-Focused Stocks Flying Under the Radar
Receive News & Ratings for Aptamer Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptamer Group and related companies with MarketBeat.com's FREE daily email newsletter.
